Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership... ( Med Discover...)

Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement

Date:11/19/2008

Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up.

Laval, Quebec (PRWEB) November 19, 2008 -- Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up.

The first project pursued by the partners is Med Discovery's kallikrein inhibitor MDPK67b, a recombinant therapeutic protein which regulates different biological pathways involved in prostate cancer. The activity of MDPK67b has been validated in animal models of human prostate tumors.

Under the terms of this agreement, Laborium Biopharma will complete the bacterial production process and scale-up, and produce cGMP clinical material required to perform Phase I/IIa clinical trials.

Dr. David Deperthes, President and CEO at Med Discovery, commented: "This ambitious project requires a high level of technical expertise and top quality processes that meet the strictest regulatory standards. This collaboration is crucial, as it provides the platform for the development of our early-phase projects. We believe that Laborium Biopharma represents the ideal partner to help us successfully complete this critical phase of our MDPK67b development program."

Luc Dubois, President of Laborium Biopharma, said: "We are very pleased to collaborate with Med Discovery, a bright and innovative company and are proud of their trust in our capabilities. We will work diligently to help Med Discovery meet the strategic objective of testing its promising therapeutic protein in humans before the end of 2009."

Med Discovery S.A. is a private biopharmaceutical company h
'/>"/>

1

GOOD

Page: 1 2
Related biology technology :

1. Telik Announces New TRAP Drug Discovery Agreement
2. MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
3. TIBCO Speeds Drug Discovery for Chemists
4. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
5. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
6. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
7. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
8. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
9. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
10. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
11. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts

Post Your Comments:

Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership...( Med Discover...)